Comorbidities, multimorbidity and COVID-19

2023/02/01 by Clark D. Russell, Clark D Russell, Nazir Lone +2 · 1 voice · 2 citations
Medicine · #COVID-19 Clinical Research Studies #Long-Term Effects of COVID-19 #SARS-CoV-2 and COVID-19 Research

paper · pdf · doi:10.1038/s41591-022-02156-9

crossref issued 2023/02/01 · crossref published 2023/02/01 · crossref published-print 2023/02/01 · openalex publication_date 2023/02/01 · crossref published-online 2023/02/16 · crossref created 2023/02/16 · crossref deposited 2023/02/20 · openalex created_date 2025/10/10 · crossref indexed 2026/07/29 · openalex updated_date 2026/07/29

Citations

• Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
• Clinical Characteristics of Coronavirus Disease 2019 in China
• Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis
• Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study
• Dexamethasone in Hospitalized Patients with Covid-19
• Factors associated with COVID-19-related death using OpenSAFELY
• Genetic mechanisms of critical illness in COVID-19
• Post-acute COVID-19 syndrome
• Association between multimorbidity and mortality in a cohort of patients admitted to hospital with COVID-19 in Scotland
• Dexamethasone in Hospitalized Patients with Covid-19.
• Long COVID after breakthrough SARS-CoV-2 infection
• Human lungs show limited permissiveness for SARS-CoV-2 due to scarce ACE2 levels but virus-induced expansion of inflammatory macrophages

Cited by

• Artificial intelligence in smart drug delivery systems: a step toward personalized medicine
• Chronic Disease Symptoms Self-Managed by Cannabis During the COVID-19 Pandemic: Results from the COVID-19 Cannabis Health Study

Discussions

• doi.org/10.1038/s415... [bsky, 1 points, 0 comments]